Building better biomaterials for cancer treatments

Updated on: March 09,2025

Building better biomaterials for cancer treatments

Updated on:March 09,2025

Weakness in lung cancer's defenses found—an enzyme that boosts cancer cell metabolism

Updated on: March 08,2025

Weakness in lung cancer's defenses found—an enzyme that boosts cancer cell metabolism

Updated on:March 08,2025

Natural killer cells offer hope for hard-to-treat pediatric sarcomas

byUniversity of QueenslandEphrin type-A receptor-2 (EphA2) and natural killer (NK) cell infiltration correspond with sarcoma survival. Credit:Clinical and Translational Medicine(2025

Updated on: February 20,2025

Natural killer cells offer hope for hard-to-treat pediatric sarcomas

byUniversity of QueenslandEphrin type-A receptor-2 (EphA2) and natural killer (NK) cell infiltration correspond with sarcoma survival. Credit:Clinical and Translational Medicine(2025

Updated on:February 20,2025

Sickle cell disease is a genetic disorder that causes lifelong suffering—here's what you need to know

by Cristina Pina and Victor Hernandez-Hernandez,The ConversationCredit: National Institutes of HealthRight now, approximately20 billion red blood cellsare busy traveling through your

Updated on: February 18,2025

Sickle cell disease is a genetic disorder that causes lifelong suffering—here's what you need to know

by Cristina Pina and Victor Hernandez-Hernandez,The ConversationCredit: National Institutes of HealthRight now, approximately20 billion red blood cellsare busy traveling through your

Updated on:February 18,2025

Overcoming glioblastoma resistance to chemotherapy

byInstitute for Basic ScienceThe "onion model" illustrates how the one-by-one inactivation of the DNA repair pathways brings about changes in TMZ-induced mutational signatures. Every &

Updated on: January 23,2025

Overcoming glioblastoma resistance to chemotherapy

byInstitute for Basic ScienceThe "onion model" illustrates how the one-by-one inactivation of the DNA repair pathways brings about changes in TMZ-induced mutational signatures. Every &

Updated on:January 23,2025

Low-dose plasma treatment shows promise for slowing down tumor growth

by Nie Lili and Zhao Weiwei,Chinese Academy of SciencesUnder the influence of electrodes, low-temperature plasma emits a purple glow in the laboratory. Credit: Nie LiliA recent study has shown t

Updated on: January 23,2025

Low-dose plasma treatment shows promise for slowing down tumor growth

by Nie Lili and Zhao Weiwei,Chinese Academy of SciencesUnder the influence of electrodes, low-temperature plasma emits a purple glow in the laboratory. Credit: Nie LiliA recent study has shown t

Updated on:January 23,2025

Putting the brakes on prostate cancer cells: Androgen receptor can alter normal prostate growth

by Alan Dove,Cornell UniversityA clump of prostate cancer cells. The blue-green cells are growing, whereas the pink ones are dying by programmed cell death (apoptosis). Credit: Dave McCarthy and

Updated on: January 23,2025

Putting the brakes on prostate cancer cells: Androgen receptor can alter normal prostate growth

by Alan Dove,Cornell UniversityA clump of prostate cancer cells. The blue-green cells are growing, whereas the pink ones are dying by programmed cell death (apoptosis). Credit: Dave McCarthy and

Updated on:January 23,2025

New microscopy technique could enable rapid tumor analysis in the operating room

byCalifornia Institute of TechnologyThese images show the high resolution achieved with the new microscopy technique. A mouse brain cross-section as seen with photoacoustic imaging is shown in t

Updated on: January 22,2025

New microscopy technique could enable rapid tumor analysis in the operating room

byCalifornia Institute of TechnologyThese images show the high resolution achieved with the new microscopy technique. A mouse brain cross-section as seen with photoacoustic imaging is shown in t

Updated on:January 22,2025

Engineered CAR-NK cells offer an alternative approach to fighting leukemia

Engineered CAR-NK cells offer an alternative approach to fighting leukemiaby Markus Bernards,Goethe University Frankfurt am MainGeneration process and evaluation of CRISPR/Cas9 knockout for CAR3

Updated on: January 22,2025

Engineered CAR-NK cells offer an alternative approach to fighting leukemia

Engineered CAR-NK cells offer an alternative approach to fighting leukemiaby Markus Bernards,Goethe University Frankfurt am MainGeneration process and evaluation of CRISPR/Cas9 knockout for CAR3

Updated on:January 22,2025

Treating advanced prostate cancer

by Nicole Ferrara,Mayo ClinicCredit: Pixabay/CC0 Public DomainAdvanced prostate cancer is cancer that has spread beyond the prostate to distant parts of the body. It is also called metastatic or

Updated on: January 22,2025

Treating advanced prostate cancer

by Nicole Ferrara,Mayo ClinicCredit: Pixabay/CC0 Public DomainAdvanced prostate cancer is cancer that has spread beyond the prostate to distant parts of the body. It is also called metastatic or

Updated on:January 22,2025

Reactive cysteines on peptide antigens may unlock new cancer immunotherapy possibilities

by Olivia Dimmer,Northwestern UniversityDevelopment of cell-impermeable cysteine-reactive probes. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-54139-8Northwestern Medi

Updated on: January 22,2025

Reactive cysteines on peptide antigens may unlock new cancer immunotherapy possibilities

by Olivia Dimmer,Northwestern UniversityDevelopment of cell-impermeable cysteine-reactive probes. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-54139-8Northwestern Medi

Updated on:January 22,2025

Tailored cancer treatment: Research predicts which patients benefit from immunotherapy

byFree University of BrusselsThe99mTechnetium-labeled anti-CD163 immunotracer shows specific in vivo binding to CD163+cells. (A and B) Representative μSPECT/CT images (3D MIP) of CD1

Updated on: January 22,2025

Tailored cancer treatment: Research predicts which patients benefit from immunotherapy

byFree University of BrusselsThe99mTechnetium-labeled anti-CD163 immunotracer shows specific in vivo binding to CD163+cells. (A and B) Representative μSPECT/CT images (3D MIP) of CD1

Updated on:January 22,2025